Multiphasic effect of morphine on the release of substance P from rat trigeminal nucleus slices
- PMID: 1378346
- DOI: 10.1016/0006-8993(92)90050-j
Multiphasic effect of morphine on the release of substance P from rat trigeminal nucleus slices
Abstract
It is generally accepted that morphine acts presynaptically to inhibit substance P (SP) release from afferent terminals in the trigeminal nucleus. Recent studies, however, provide evidence that opioids produce both inhibitory and excitatory effects on SP release which are concentration- and receptor subtype-dependent. In the present study, we have examined a wide range of morphine concentrations on K(+)-evoked SP release from rat trigeminal nucleus caudalis slices. Immunoreactive SP was measured in perfusates. Morphine produced multiphasic effects on K(+)-evoked SP release without affecting basal release. A very low nanomolar concentration (1 nM) suppressed release, higher nanomolar concentrations (100-300 nM) facilitated release, a low micromolar concentration (3 microM) suppressed release, and a higher micromolar concentration (30 microM) facilitated release. These effects were abolished by opioid receptor blockade with naloxone (30 nM). Thus, morphine produces a complex bi-directional modulation of SP release from TNC which is concentration- and possibly receptor subtype-dependent.
Similar articles
-
Multiphasic morphine modulation of substance P release from capsaicin-sensitive primary afferent fibers.Neurochem Res. 1999 Oct;24(10):1203-7. doi: 10.1023/a:1020963120333. Neurochem Res. 1999. PMID: 10492514
-
Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes.Brain Res. 1992 May 8;579(2):195-203. doi: 10.1016/0006-8993(92)90051-a. Brain Res. 1992. PMID: 1378347
-
Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons.Neurosci Lett. 1995 Jul 14;194(1-2):41-4. doi: 10.1016/0304-3940(95)11721-8. Neurosci Lett. 1995. PMID: 7478208
-
Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.Eur J Pharmacol. 1992 Dec 8;229(1):1-7. doi: 10.1016/0014-2999(92)90278-c. Eur J Pharmacol. 1992. PMID: 1282103
-
Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.J Pharmacol Exp Ther. 1993 Feb;264(2):648-53. J Pharmacol Exp Ther. 1993. PMID: 7679733
Cited by
-
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Pharmacol Rev. 2011 Sep;63(3):772-810. doi: 10.1124/pr.110.004135. Epub 2011 Jul 13. Pharmacol Rev. 2011. PMID: 21752874 Free PMC article. Review.
-
Capsaicin-evoked iCGRP release from human dental pulp: a model system for the study of peripheral neuropeptide secretion in normal healthy tissue.Pain. 2009 Aug;144(3):253-261. doi: 10.1016/j.pain.2009.03.027. Epub 2009 May 9. Pain. 2009. PMID: 19428185 Free PMC article. Clinical Trial.
-
Multiphasic morphine modulation of substance P release from capsaicin-sensitive primary afferent fibers.Neurochem Res. 1999 Oct;24(10):1203-7. doi: 10.1023/a:1020963120333. Neurochem Res. 1999. PMID: 10492514
-
A computational strategy for finding novel targets and therapeutic compounds for opioid dependence.PLoS One. 2018 Nov 7;13(11):e0207027. doi: 10.1371/journal.pone.0207027. eCollection 2018. PLoS One. 2018. PMID: 30403753 Free PMC article.
-
A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism.Mol Pain. 2010 Jun 2;6:33. doi: 10.1186/1744-8069-6-33. Mol Pain. 2010. PMID: 20525224 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous